Φορτώνει......
Salicylamide Enhances Melanin Synthesis in B16F1 Melanoma Cells
Salicylamide, a non-steroidal anti-inflammatory drug (NSAID), is used as an analgesic and antipyretic agent. We have previously shown that several NSAIDs have anti-melanogenic properties in B16F1 melanoma cells. In contrast, we have found that salicylamide enhances melanin contents in B16F1 melanoma...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Biomol Ther (Seoul) |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
The Korean Society of Applied Pharmacology
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8255140/ https://ncbi.nlm.nih.gov/pubmed/33731492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4062/biomolther.2020.222 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|